Proposals to Accelerate Novel Vaccine Development for Children.
作者信息
Permar Sallie, Creech C Buddy, Edwards Kathryn M, Walter Emmanuel B
机构信息
Weill Cornell Medicine, New York, NY, United States;
Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
出版信息
Pediatrics. 2021 Oct 22;149(1). doi: 10.1542/peds.2021-054593.
Abstract
摘要
相似文献
1
Proposals to Accelerate Novel Vaccine Development for Children.加速儿童新型疫苗研发的建议。
Pediatrics. 2021 Oct 22;149(1). doi: 10.1542/peds.2021-054593.
2
Proposals to Accelerate Novel Vaccine Development for Children.
Pediatrics. 2021 Dec 10. doi: 10.1542/peds.2021-054593.
3
Electronic Health Record and Semantic Issues Using Fast Healthcare Interoperability Resources: Systematic Mapping Review.电子健康记录与 Fast Healthcare Interoperability Resources 的语义问题：系统映射综述。
J Med Internet Res. 2024 Jan 30;26:e45209. doi: 10.2196/45209.
4
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.如何加速向全球所有人群供应疫苗？第二部分：利用 COVID-19 情况汲取的行业初步经验教训和详细技术反思。
Vaccine. 2022 Feb 23;40(9):1223-1230. doi: 10.1016/j.vaccine.2021.12.038.
5
Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan.制定国家卫生政策逻辑模型以加速肿瘤学和姑息治疗的整合：日本全国范围内的德尔菲调查。
Int J Clin Oncol. 2022 Sep;27(9):1529-1542. doi: 10.1007/s10147-022-02201-0. Epub 2022 Jun 17.
6
The art of partnerships for vaccines.疫苗伙伴关系的艺术。
Vaccine. 2019 Sep 20;37(40):5909-5919. doi: 10.1016/j.vaccine.2019.07.088. Epub 2019 Aug 22.
7
Vaccines, inspiring innovation in health.疫苗，激发健康创新。
Vaccine. 2018 Nov 19;36(48):7430-7437. doi: 10.1016/j.vaccine.2018.05.035. Epub 2018 May 19.
8
COVID-19 vaccine development: a pediatric perspective.COVID-19 疫苗研发：儿科视角。
Curr Opin Pediatr. 2021 Feb 1;33(1):144-151. doi: 10.1097/MOP.0000000000000978.
9
[New proposals for machines to accelerate electrically charged telchen].
Experientia. 1946 Dec 15;2(12):490-2. doi: 10.1007/BF02137569.
10
Leveraging identity and access management technology to accelerate emergency COVID-19 vaccine delivery.利用身份和访问管理技术加速新型冠状病毒肺炎疫苗的紧急交付。
Ther Adv Vaccines Immunother. 2023 May 29;11:25151355231173830. doi: 10.1177/25151355231173830. eCollection 2023.
本文引用的文献
1
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.mRNA-1273 新型冠状病毒疫苗在青少年中的评估。
N Engl J Med. 2021 Dec 9;385(24):2241-2251. doi: 10.1056/NEJMoa2109522. Epub 2021 Aug 11.
2
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
3
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.辉瑞-BioNTech 新冠疫苗在青少年中的安全性、免疫原性和有效性。
N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.
4
In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.在高风险成年人中，第二剂接种后≥14 天， Moderna 疫苗对 COVID-19 的有效性为 94%。
Ann Intern Med. 2021 Mar;174(3):JC28. doi: 10.7326/ACPJ202103160-028. Epub 2021 Mar 2.
5
A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques.一种针对未成熟树突状细胞的趋化因子融合疫苗可在婴儿恒河猴中引发针对疟疾子孢子的高抗体应答。
Sci Rep. 2021 Jan 13;11(1):1220. doi: 10.1038/s41598-020-79427-3.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件